Benchmark Reiterates Buy on Select Medical Hldgs, Maintains $39 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Bill Sutherland has reiterated a 'Buy' rating on Select Medical Holdings (NYSE:SEM) and maintained a price target of $39.
November 08, 2023 | 6:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst has reiterated a 'Buy' rating on Select Medical Holdings and maintained a price target of $39.
The reiteration of a 'Buy' rating by a Benchmark analyst and the maintenance of a $39 price target indicates a positive outlook for Select Medical Holdings. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100